Orally administered recombinant human interleukin-11 is protective in experimental neutropenic sepsis. [electronic resource]
Producer: 20030130Description: 70-6 p. digitalISSN:- 0022-1899
- Administration, Oral
- Animals
- Bacteremia -- prevention & control
- Female
- Interferon-gamma -- genetics
- Interleukin-11 -- administration & dosage
- Neutropenia -- drug therapy
- RNA, Messenger -- analysis
- Rats
- Rats, Sprague-Dawley
- Recombinant Proteins -- administration & dosage
- Tumor Necrosis Factor-alpha -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.